DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Sun Pharma Advanced Research Company Limited — Outcome of Board Meeting

NSE 2 hrs ago·2 Nov 2026, 2:16 pm

SUN Pharma Adv.res.co

Sun Pharma Advanced Research Company Limited has announced its unaudited financial results for the quarter and half year ended September 30, 2026. The company has submitted these results to the stock exchange, providing an update on its financial performance during this period.

For investors, this disclosure is a routine step that signals the company's adherence to regulatory reporting standards. It offers a snapshot of the company's operational health and financial standing as of the reporting date, allowing stakeholders to track its progress.

Investors should watch for the specific details within the results, such as revenue growth, profit margins, and any commentary on the company's strategic initiatives. These figures will help in assessing the company's current trajectory and future outlook.